Literature DB >> 7480554

Smoking, processing speed and attention in a choice reaction time task.

T Bates1, G Mangan, C Stough, P Corballis.   

Abstract

Nineteen subjects performed a choice reaction time task in which two levels of choice (two and four stimuli), and two levels of spatial attention (narrow and wide) were manipulated under each of two smoking conditions: sham smoking (denicotinised cigarette) or regular smoking (0.8 mg nicotine cigarette). All three factors significantly affected reaction time, with the smallest reaction times being recorded to the two-choice narrow grouped stimuli recorded under the high nicotine condition. Nicotine appears to speed decision time for both complex and hard-to-attend tasks, which is compatible with a role for nicotinic receptors in systems jointly mediating attention, memory and processing speed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7480554     DOI: 10.1007/bf02246195

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  16 in total

1.  Psychomotor performance in smokers following single and repeated doses of nicotine gum.

Authors:  N Sherwood; J S Kerr; I Hindmarch
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Cholinergic activity and constraints on information processing.

Authors:  E Callaway; R Halliday; H Naylor
Journal:  Biol Psychol       Date:  1992-05       Impact factor: 3.251

3.  Inspection time and measured intelligence.

Authors:  T Nettelbeck; M Lally
Journal:  Br J Psychol       Date:  1976-02

4.  Effects of nicotine on perceptual speed.

Authors:  C Stough; G Mangan; T Bates; N Frank; B Kerkin; O Pellett
Journal:  Psychopharmacology (Berl)       Date:  1995-06       Impact factor: 4.530

5.  Combined effects of tobacco and caffeine on the components of choice reaction-time heart rate, and hand steadiness.

Authors:  D L Smith; J E Tong; G Leigh
Journal:  Percept Mot Skills       Date:  1977-10

6.  The N1 wave of the human electric and magnetic response to sound: a review and an analysis of the component structure.

Authors:  R Näätänen; T Picton
Journal:  Psychophysiology       Date:  1987-07       Impact factor: 4.016

Review 7.  Cholinergic control of cognitive resources.

Authors:  D M Warburton; J M Rusted
Journal:  Neuropsychobiology       Date:  1993       Impact factor: 2.328

8.  Impaired cognitive shifting in parkinsonian patients on anticholinergic therapy.

Authors:  K P Van Spaendonck; H J Berger; M W Horstink; E L Buytenhuijs; A R Cools
Journal:  Neuropsychologia       Date:  1993-04       Impact factor: 3.139

9.  Smoking and Raven IQ.

Authors:  C Stough; G Mangan; T Bates; O Pellett
Journal:  Psychopharmacology (Berl)       Date:  1994-11       Impact factor: 4.530

10.  Cholinergic lesions of mouse striatum induced by AF64A alter D2 dopaminergic behavior and reduce D2 dopamine receptors and D2 dopamine receptor mRNA.

Authors:  L W Zhou; S P Zhang; T A Connell; B Weiss
Journal:  Neurochem Int       Date:  1993-03       Impact factor: 3.921

View more
  14 in total

1.  C957T polymorphism of the dopamine D2 receptor gene modulates the effect of nicotine on working memory performance and cortical processing efficiency.

Authors:  Leslie K Jacobsen; Kenneth R Pugh; W Einar Mencl; Joel Gelernter
Journal:  Psychopharmacology (Berl)       Date:  2006-08-09       Impact factor: 4.530

2.  Transdermal Nicotine for the Treatment of Mood and Cognitive Symptoms in Nonsmokers With Late-Life Depression.

Authors:  Jason A Gandelman; Hakmook Kang; Ashleigh Antal; Kimberly Albert; Brian D Boyd; Alexander C Conley; Paul Newhouse; Warren D Taylor
Journal:  J Clin Psychiatry       Date:  2018-08-28       Impact factor: 4.384

3.  Meta-analysis of the acute effects of nicotine and smoking on human performance.

Authors:  Stephen J Heishman; Bethea A Kleykamp; Edward G Singleton
Journal:  Psychopharmacology (Berl)       Date:  2010-04-24       Impact factor: 4.530

Review 4.  A review of the effects of very low nicotine content cigarettes on behavioral and cognitive performance.

Authors:  Diana R Keith; Allison N Kurti; Danielle R Davis; Ivori A Zvorsky; Stephen T Higgins
Journal:  Prev Med       Date:  2017-06-21       Impact factor: 4.018

5.  Nicotine derived from the electronic cigarette improves time-based prospective memory in abstinent smokers.

Authors:  Lynne Dawkins; John Turner; Eadaoin Crowe
Journal:  Psychopharmacology (Berl)       Date:  2013-01-24       Impact factor: 4.530

6.  Effects of treatment for tobacco dependence on resting cerebral glucose metabolism.

Authors:  Matthew R Costello; Mark A Mandelkern; Stephen Shoptaw; Stephanie Shulenberger; Stephanie K Baker; Anna L Abrams; Catherine Xia; Edythe D London; Arthur L Brody
Journal:  Neuropsychopharmacology       Date:  2009-10-28       Impact factor: 7.853

7.  Nicotine enhances visuospatial attention by deactivating areas of the resting brain default network.

Authors:  Britta Hahn; Thomas J Ross; Yihong Yang; Insook Kim; Marilyn A Huestis; Elliot A Stein
Journal:  J Neurosci       Date:  2007-03-28       Impact factor: 6.167

8.  Chronic nicotine improves cognitive performance in a test of attention but does not attenuate cognitive disruption induced by repeated phencyclidine administration.

Authors:  Nurith Amitai; Athina Markou
Journal:  Psychopharmacology (Berl)       Date:  2008-07-11       Impact factor: 4.530

9.  Daily cannabis use in adolescents who smoke tobacco is associated with altered late-stage feedback processing: A high-density electrical mapping study.

Authors:  Kristen P Morie; Jia Wu; Marc N Potenza; Suchitra Krishnan-Sarin; Linda C Mayes; Christopher J Hammond; Michael J Crowley
Journal:  J Psychiatr Res       Date:  2021-05-23       Impact factor: 4.791

10.  Chronic nicotine administration improves attention while nicotine withdrawal induces performance deficits in the 5-choice serial reaction time task in rats.

Authors:  Svetlana Semenova; Ian P Stolerman; Athina Markou
Journal:  Pharmacol Biochem Behav       Date:  2007-05-23       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.